Discover Drugs - Pharma on Medika Life

How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Why We Should Be Cautious With COVID-19 Medical Research

Dr Jeff Livingston - May 25, 2020

Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Medika Life - December 22, 2020

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

BIO – Biotech Without Borders

How COVID and the Power of Now Killed Scientific Peer Review

Real-World Repercussions of Mislabeling Treatments as Vaccines

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

LATEST

TRENDING

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

Phexxi; Have You Heard About This New Hormone-Free Contraceptive?

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FDA Approval of New Drug for Alzheimer’s Offers Hope

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

The Role of Drugs in Combating Obesity and How These Drugs Affect Your Health

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

How COVID and the Power of Now Killed Scientific Peer Review

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Why We Should Be Cautious With COVID-19 Medical Research

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories